Business & Markets
TUSPAN syrup is the newest addition to our OTC portfolio based on extract of ivy leaf.
Strongly committed with local communities and people wellness, we have been integrating...
Jump to navigation
Sopharma AD has an established medical governance unit with focus on post-authorization product information management.
Led by industry Code of conduct we have developed adequate processes and procedures to ensure our promotional practices are ethical and lawful. Providing accurate and complete information to
is our commitment.
Sopharma AD takes responsibility to gather additional information about a medicine's safety, efficacy and optimal use after the regulatory approval. For its branded products the company performs post-authorization studies, published on the web site of the European clinical trials data base.